New board appointment at Madeira Therapeutics
This article was originally published in Scrip
Executive Summary
Dr Gregory Kearns, chairman of the department of medical research and director of the paediatric pharmacology research unit at Children's Mercy Hospitals and Clinics in Kansas City, Missouri, has been elected to serve as a member of Madeira Therapeutics' board of advisors. Madeira is a privately held company specialising in paediatric pharmaceuticals.